miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1
Stephanie Ma(University of Hong Kong - Shenzhen Hospital), Xin‐Yuan Guan(Sun Yat-sen University), Pak Shing Kwan(Queen Mary Hospital), Kwan Ho Tang(AstraZeneca (Netherlands)), Chung Mau Lo(City University of Hong Kong), Antonia Castilho(Queen Mary Hospital), Ka‐Fai To(Chinese University of Hong Kong), Irene Oi‐Lin Ng(University of Hong Kong), Kwok Wah Chan(Queen Mary Hospital), Nathalie Wong(Chinese University of Hong Kong), Kwan Man(University of Hong Kong - Shenzhen Hospital), Yuen Piu Chan(Queen Mary Hospital), Terence K. Lee(Hong Kong Polytechnic University), Bo-Jian Zheng(University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong)
Cited by 386
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
|Proceedings of the National Academy of Sciences|2015|818